A randomized, double-blind, multicenter, multifactorial, placebo-controlled, parallel group study to evaluate the efficacy and safety of valsartan and amlodipine combined and alone in hypertensive patients.
Phase of Trial: Phase III
Latest Information Update: 13 Oct 2009
At a glance
- Drugs Amlodipine; Valsartan
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Novartis
- 30 Dec 2006 New trial record.